Equity Research firms currently have a positive stance on shares of Corindus Vascular Robotics Inc. (:CVRS). The majority of analysts covering the equity have a consensus Strong Buy recommendation on the stock, yielding a score of 1.50. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $2.75 on a short term basis.
At the time of writing, the stock was trading at $1.11. This represents a change from the opening price of -9.76%. In terms of performance, year to date, the stock is -66.04%. The monthly stock performance comes in at -14.84%. For the quarter, shares are performing at -18.05%. Weekly performance analysis shows the equity at -0.91%.
In taking a look at technical levels, shares are trading -12.25% away from the 50 day simple moving average and -23.75% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -68.29% away from it’s 52- week high and 51.85% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Corindus Vascular Robotics Inc.’s RSI stands at 40.16. In looking at volatility levels, the shares saw weekly volatility of 9.08% and 7.47% over the past month.